Prognostic Role of Primary Non Small Cell Lung Carcinoma Standardized F18-FDG Uptake Values (SUV and TLG) Measured With F18-fluorodeoxyglucose Positron Emission Tomography (F18-FDG-PET): a Non Interventional Study.
NCT00759382 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 340
Last updated 2021-08-23
Summary
The primary aim of this non interventional study is to assess the independent prognostic role on overall survival of primary tumour 18F-FDG uptake value (SUVmax) measured on 18fluorodeoxyglucose positron emission tomography (18F-FDG-PET) in patients with non-metastatic non-small cell lung cancers treated with curative intent, taking into account the other conventional prognostic factors (performance status, age, sex, disease stage).
Conditions
- Non Small Cell Lung Carcinoma
Sponsors & Collaborators
-
European Lung Cancer Working Party
lead OTHER
Principal Investigators
-
Thierry Berghmans, MD · European Lung Cancer Working Party
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-07-31
- Primary Completion
- 2021-01-31
- Completion
- 2022-01-31
Countries
- Belgium
Study Locations
More Related Trials
-
Fludeoxyglucose F 18 in Detecting Lymph Node Metastasis in Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed by Surgery
NCT00732563 ·Status: COMPLETED ·Phase: NA
-
PET Imaging in Potentially Surgically Resectable Non-small Cell Lung Cancers
NCT00136890 ·Status: COMPLETED ·Phase: PHASE3
-
Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung Cancer
NCT00603057 ·Status: COMPLETED
-
Diagnostic Significance of Single Center, Open and Prospective Evaluation of <Sup>18<Sup>F-FDG PET/CT Dynamic Imaging and Genomic Sequencing in Detecting Metastatic Lesions and Differentiating Multiple Primary Lung Cancer From Intrapulmonary Metastases of Non-small Cell Lung Cancer
NCT03679936 ·Status: UNKNOWN
-
Comprehensive Geriatric Assessment and Complications Following Lung Resection for Lung Cancer
NCT01956331 ·Status: COMPLETED
-
Prediction of Response to Treatment With Immunotherapy + Chemotherapy in Non-Small Cell Lung Cancer
NCT04589013 ·Status: COMPLETED
-
Surveillance For New Lung Primaries
NCT00205439 ·Status: TERMINATED
-
Pathological and Nuclear Medicine Factors for Prognosis in Lung Carcinoma
NCT04276025 ·Status: COMPLETED
-
Correlation of Metabolic Imaging With Immune Markers in NSCLC Candidate to Immunotherapy.
NCT03563482 ·Status: UNKNOWN ·Phase: NA
-
PRedictive Value of Multiparametric Dynamic WB 18F-FDG-PET Imaging on a LAFOV System for FIRST-line Chemo-immunotherapy Efficacy in Advanced Non-small-cell Lung Cancer: PROFIL-1
NCT06738680 ·Status: NOT_YET_RECRUITING
-
Fluorescence Bronchoscopy and Molecular Characterization of Abnormal Bronchial Lesions: Novel Approaches for Early Detection of Lung Cancer in High Risk Patients
NCT00512642 ·Status: COMPLETED
-
Screening for Lung Cancer in Current or Past Smokers With Chronic Obstructive Pulmonary Disease
NCT00512746 ·Status: COMPLETED ·Phase: NA
-
Structuring of a Lung Cancer Screening Program Including Clinical, Radiological and Biological Phenotyping Useful for the Development of Individualized Risk Prediction Tools: PREVALUNG ETOILE
NCT05649046 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Decoding the Association of Imaging and Tumor Microenvironment in Lung Cancer Using Radiogenomic Approach(Radiogenomics-Lung)
NCT06500312 ·Status: RECRUITING
-
Maximizing Benefit of Lung Cancer Screening Incidental Findings of Cardiovascular, Respiratory and Breast Measures
NCT05900544 ·Status: WITHDRAWN ·Phase: NA
-
A Study to Examine Biomarkers From Lung and Blood Samples in Participants With Suspected Lung Cancer
NCT04951154 ·Status: COMPLETED
-
Surveillance With PET/CT and Liquid Biopsies of Stage I-III Lung Cancer Patients After Completion of Definitive Therapy
NCT03740126 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Prospective Observational Study on ES-SCLC
NCT07173946 ·Status: NOT_YET_RECRUITING
-
Surveillance For New Lung Primaries
NCT00205413 ·Status: TERMINATED
-
PET/CT Scan as a Tool to Rationalize the Treatment of of Advanced NSCLC Patients Undergoing First Chemotherapy
NCT02035683 ·Status: UNKNOWN ·Phase: NA
-
A Machine Learning Approach to Identify Patients With Resected Non-small-cell Lung Cancer With High Risk of Relapse
NCT05732974 ·Status: RECRUITING
-
Observing Patients With Palliative Asymptomatic Centrally Located Advanced Non-small Cell Lung Carcinoma (NSCLC)
NCT01279408 ·Status: COMPLETED
-
The Utility and Cost-Effectiveness Analysis of 18F-FDG PETin Staging Potential Operable Non-Small Cell Lung Cancer
NCT00364663 ·Status: UNKNOWN
-
Assessment of Invasive Mediastinal Staging in cN1 Lung Cancer.
NCT01456429 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Impact of Polynuclear Neutrophils' Intra-tumoral Rate and the Mutational Status in Pulmonary Adenocarcinomas on Survival
NCT04761640 ·Status: UNKNOWN